人工智能提高医生识别前列腺癌范围的能力
一项多读者多病例研究比较了7名泌尿外科医生和3名放射科医生在50例根治性前列腺切除病例中,使用人工智能(AI)软件与标准方法勾画肿瘤边界的表现。以全mount病理切片肿瘤边界为参考,AI辅助勾画的平衡准确率(84.7%)优于认知勾画(67.2%)和半腺勾画(75.9%),且负切缘率(72.8% vs 1.6%)显著更高。结论认为AI辅助勾画可减少对前列腺癌范围的低估。
要点
- AI辅助勾画的平衡准确率为84.7%,优于认知勾画67.2%和半腺勾画75.9%(P < .0001)。
- 认知勾画负切缘率仅1.6%,AI辅助勾画为72.8%(P < .0001)。
- 认知勾画系统性地低估了癌症范围。
核心结论
- AI辅助癌症勾画可减少对前列腺癌范围的低估,显著提高医生勾画的准确率和负切缘率。
- 该技术可能改善结局,因为准确的勾画有助于制定患者管理策略并支撑治疗的肿瘤学疗效。
研究设计与样本
- 多读者多病例研究,比较医生使用人工智能(AI)与标准诊疗方法进行肿瘤勾画的性能。
- 病例由来自5个机构的7名泌尿外科医生和3名放射科医生解读,经验为2至23年。
- 每位读者回顾性评估50例适合局灶治疗的根治性前列腺切除病例。
- 每例包括T2加权MRI、前列腺和可疑癌症感兴趣区域的勾画以及活检报告。
- 读者先认知勾画癌症边界,至少4周后使用AI软件对相同病例进行勾画。
主要发现
- AI辅助癌症勾画的平衡准确率(体素级敏感度和特异度的均值)为84.7%,优于认知勾画67.2%和半腺勾画75.9%(P < .0001)。
- 认知勾画癌症边界系统性地低估癌症范围,负切缘率为1.6%,而AI辅助癌症勾画为72.8%(P < .0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Defining prostate cancer contours is a complex task, undermining the efficacy of interventions such as focal therapy. A multireader multicase study compared physicians' performance using artificial intelligence (AI) vs standard-of-care methods for tumor delineation. MATERIALS AND METHODS: Cases were interpreted by 7 urologists and 3 radiologists from 5 institutions with 2 to 23 years of experience. Each reader evaluated 50 prostatectomy cases retrospectively eligible for focal therapy. Each case included a T2-weighted MRI, contours of the prostate and region(s) of interest suspicious for cancer, and a biopsy report. First, readers defined cancer contours cognitively, manually delineating tumor boundaries to encapsulate all clinically significant disease. Then, after ≥ 4 weeks, readers contoured the same cases using AI software. Using tumor boundaries on whole-mount histopathology slides as ground truth, AI-assisted, cognitively-defined, and hemigland cancer contours were evaluated. Primary outcome measures were the accuracy and negative margin rate of cancer contours. All statistical analyses were performed using generalized estimating equations. RESULTS: The balanced accuracy (mean of voxel-wise sensitivity and specificity) of AI-assisted cancer contours (84.7%) was superior to cognitively-defined (67.2%) and hemigland contours (75.9%; P < .0001). Cognitively-defined cancer contours systematically underestimated cancer extent, with a negative margin rate of 1.6% compared to 72.8% for AI-assisted cancer contours (P < .0001). CONCLUSIONS: AI-assisted cancer contours reduce underestimation of prostate cancer extent, significantly improving contouring accuracy and negative margin rate achieved by physicians. This technology can potentially improve outcomes, as accurate contouring informs patient management strategy and underpins the oncologic efficacy of treatment.
引用
- Mota SM, Priester A, Shubert J, et al. Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent. J Urol. 2024. PMID: 38860576. doi:10.1097/JU.0000000000003960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。